Task force endorses move toward natural psychedelics for clinical, recreational use

OG article by Danielle J. Brown

November 11, 2025

Maryland’s Task Force on Responsible Use of Natural Psychedelic Substances recommends a phased approach: (1) build regulations and deprioritize personal possession of psilocybin; (2) allow medical use under oversight; (3) expand to commercial sales and other substances (DMT, mescaline excluding peyote). The report cites promising research for PTSD and treatment-resistant depression but warns of risks without professional guidance. Lawmakers note implementation will take years and stress cultural respect for Indigenous traditions. MedChi urges caution and evidence-based policy.